Organization | Provident Clinical Research

Provident Clinical Research Report issue

For profit Phase 3 Phase 4

Founded: Rockville MD United States (2009)

Organization Overview

First Clinical Trial

2009

NCT00692731

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2013

Timeline

NOW

Now

Alternative names

Providence Clinical Research | Provident Clinical Research, Addison, IL

Active Ingredients

Drugs in Phase 4 Trials (5)

cholestyramine (questran) (2 trials)

colesevelam (welchol) (1 trial)

icosapent ethyl (vascepa) (6 trials)

simvastatin (zocor) (2 trials)

Drugs in Phase 3 Trials (2)

traumeel (1 trial)

Drugs in Other Trials (5)

catechin (1 trial)

soybean oil (1 trial)

soy protein (1 trial)

stearidonic acid (1 trial)

sunflower oil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Dyslipidemias (Phase 4)

Hypercholesterolemia (Phase 4)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 11
# of Trial APIs: 12